Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Targeting annexin A2 reduces tumorigenesis and therapeutic resistance of nasopharyngeal carcinoma.

Oncotarget - 29 Sept 2015

Chen Chang-Yu, Lin Yung-Song, Chen Chi-Long, Chao Pin-Zhir, Chiou Jeng-Fong, Kuo Chia-Chun, Lee Fei-Peng, Lin Yung-Feng, Sung Yu-Hsuan, Lin Yun-Tien, Li Chang-Fan, Chen Yin-Ju, Chen Chien-Ho

Abstract excerpt

The expression of annexin A2 (ANXA2) in nasopharyngeal carcinoma (NPC) cells induces the immunosuppressive response in dendritic cells; however, the oncogenic effect and clinical significance of ANXA2 have not been fully investigated in NPC cells. Immunohistochemical staining for ANXA2 was performed in 61 patients and the association with clinicopathological status was determined. Short hairpin (sh)RNA knockdown...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Annexin A2
Share to Carcinoma

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cell Adhesion

Share to Epithelial-Mesenchymal Transition

Share to Gene Silencing

Share to Nasopharyngeal Carcinoma

Share to Nasopharyngeal Neoplasms

Share to RNA, Small Interfering

Source

Open in PubMed Open full text

Identifiers

PMID: 26196246
DOI: 10.18632/oncotarget.4521
PMCID: PMC4694965

Genes

ANXA2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Targeting annexin A2 reduces tumorigenesis and therapeutic resistance of nasopharyngeal carcinoma.PMID 26196246Read ↗

Association of annexin A2 with cancer development (Review)Semantic proximity Read ↗

Annexin A11(ANXA 11) facilitates oral squamous cell carcinoma progression via activating the PI3K/AKT signaling pathwaySemantic proximity Read ↗

ANXA5 predicts prognosis and immune response and mediates proliferation and migration in head and neck squamous cell carcinomaSemantic proximity Read ↗

Annexin A1 regulates EGFR activity and alters EGFR-containing tumour-derived exosomes in head and neck cancers.Semantic proximity Read ↗

ANXA2 is a potential biomarker for cancer prognosis and immune infiltration: A systematic pan-cancer analysisSemantic proximity Read ↗

Annexin A2: Its Molecular Regulation and Cellular Expression in Cancer DevelopmentSemantic proximity Read ↗

ANXA6 Contributes to Radioresistance by Promoting Autophagy via Inhibiting the PI3K/AKT/mTOR Signaling Pathway in Nasopharyngeal CarcinomaSemantic proximity Read ↗

Potential prognostic and therapeutic value of ANXA8 in renal cell carcinoma: based on the comprehensive analysis of annexins familySemantic proximity Read ↗

The potent tumor suppressor miR-497 inhibits cancer phenotypes in nasopharyngeal carcinoma by targeting ANLN and HSPA4L.Semantic proximity Read ↗

Integrative analysis of ASXL family genes reveals ASXL2 as an immunoregulatory molecule in head and neck squamous cell carcinomaSemantic proximity Read ↗

Role of Annexin 7 (ANXA7) as a tumor suppressor and a regulator of drug resistance in thyroid cancerSemantic proximity Read ↗

Multi-omics Analysis Reveals the Anti-tumor Efficacy of Calycosin in Nasopharyngeal Carcinoma and its Mechanism of Overcoming ABCC1-Mediated ResistanceSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.